Resident PhysicianCedars-Sinai Medical Center
Disclosure(s): No financial relationships to disclose
Phase 1b Study of Neoadjuvant Anti-PD-1 Immunotherapy and Stereotactic Radiation in Recurrent Glioblastoma: Feasibility and Preliminary Survival Outcomes
Saturday, April 26, 20252:23 PM – 2:26 PM EDT